Unique ID issued by UMIN | UMIN000057630 |
---|---|
Receipt number | R000065841 |
Scientific Title | Acute Lifting Program for Stroke with BMI (ALPS-BMI) Study |
Date of disclosure of the study information | 2025/04/21 |
Last modified on | 2025/04/16 14:22:05 |
Acute Lifting Program for Stroke with BMI (ALPS-BMI) Study
ALPS-BMI
Acute Lifting Program for Stroke with BMI (ALPS-BMI) Study
ALPS-BMI
Japan |
Ischemic stroke, intracerebral hemorrhage
Neurosurgery | Rehabilitation medicine |
Others
NO
This study is aimed to clarify the following issues:
1) therapeutic effects of BMI in acute stroke patients
2) stroke subtypes and locations of injury for which BMI is effective
3) predictors of patients' characteristics for which BMI is effective
Efficacy
Exploratory
Explanatory
Not applicable
FMA_UE (Fugel-Meyer assessment - upper extremity motor score) at 56 days after the start of BMI
1) 10-point sensory evaluation
2) MAL (Motor activity log)
3) Upper limb EMG and video evaluation
4) Upper extremity MEP (motor evoked potential)
5) EQ-5D (EuroQol 5-dimensions)
6) Diffusion tensor image (diffusion tensor image; DTI)
7) EEG evaluation during BMI training
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Device,equipment |
Duration of treatment: In addition to the usual rehabilitation, BMI treatment using a medical BMI device (hand type) will be performed 20 times for 30 days after enrollment. Thereafter, the patient will again undergo the usual rehabilitation required.
Observation period: 56 days after enrollment. The effect of BMI treatment will be evaluated at four time points: pre-intervention, 14 days post-intervention (interim), 28 days post-intervention (post-intervention), and 56 days post-intervention (follow-up).
18 | years-old | <= |
Not applicable |
Male and Female
Patients who meet all of the following criteria will be included in this study
(1) Patients 18 years of age or older
(2) Patients within 7 days of stroke (cerebral infarction, cerebral hemorrhage)
(3) Patients with upper limb paralysis due to stroke
(4) Patients with an FMA-UE (Fugel-Meyer assessment - upper extremity motor score) of less than 20 points and a score of 0 or 1 for group extension in the FMA C item at the time of initial evaluation
(5) Patients who have given their written consent to participate in this clinical study.
Patients who meet any of the following criteria will not be included in this study
(1) Patients with a pacemaker or implantable cardioverter-defibrillator
(2) Patients who were participating in other clinical trials prior to study entry
(3) Patients who failed to complete the initial BMI training
(4) Patients deemed ineligible by the investigator
40
1st name | Satoshi |
Middle name | |
Last name | Kuroda |
Toyama University Hospital
Neurosurgery
930-0194
2630 Sugitani, Toyama 930-0194, Japan
076-434-7348
skuroda@med.u-toyama.ac.jp
1st name | Satoshi |
Middle name | |
Last name | Kuroda |
Toyama University Hospital
Neurosurgery
930-0194
2630 Sugitani, Toyama 930-0194, Japan
076-434-7348
skuroda@med.u-toyama.ac.jp
University of Toyama
None
Self funding
IRB
2630 Sugitani, Toyama 930-0194, Japan
076-434-7348
skuroda@med.u-toyama.ac.jp
NO
2025 | Year | 04 | Month | 21 | Day |
Unpublished
Preinitiation
2025 | Year | 04 | Month | 16 | Day |
2025 | Year | 05 | Month | 01 | Day |
2027 | Year | 03 | Month | 31 | Day |
2025 | Year | 04 | Month | 16 | Day |
2025 | Year | 04 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065841